Akers Biosciences Share Discussion Threads

[rivaldo] 08/9/2014 11:38

A very positive move today, with Finncap replacing Daniel Stewart as Nomad and broker.

Finncap are MUCH more respected and have a lot more weight within the investment and small cap community.

[werewolfie] 06/9/2014 10:01

Sales/marketing staff - I was aware of Mr Hendricks appointment. Wasnt aware of Patrice Laterra McMorrow & Nicolas Daurel who both have impressive track records.

Interesting final page detailing the names and mc of the competition - all are larger than Akers


Cant post the link here but search for "dr raymond akers investor presentation" on directors talk

[mcmather] 05/9/2014 22:22

Hmmmm......

Zak Mir covers Amara Mining, Amerisur, Akers Biosciences, Bowleven, BP, Supergroup and Standard Life on Tip TV.

[tiptv1] 05/9/2014 13:48

Tip TV's reasons to BUY in Akers Bioscience (AKR) - See more at:

[mcmather] 04/9/2014 16:12

Apparently around 100 at the presentation last night:

.@AkersBio chairman presents to 100 investors in London, UK at the @proactive_uk One2One #Investor forum $AKER $AKR pic.twitter.com/APKAMAIg7m

[mcmather] 04/9/2014 16:09

Notwithstanding concerns re the options - a major issue in my opinion and which should be rescinded simply due to the staff in question not be deserving of the same - all is roughly on track in terms of forecasts for the year plus they still have $11m+ in cash / equivalents.

Bit of life on nasdaq.

[rivaldo] 04/9/2014 15:39

Cheers Aim_Trader - will take a look later.

[aim_trader] 04/9/2014 11:03

To view Akers Biosciences presentation from last night’s Proactive Investors One2One Investor Forum, click on the following link:

[deanroberthunt] 04/9/2014 08:13

wonder when the new chairman will get his gazillions of free options....

[deanroberthunt] 03/9/2014 19:15

650p only in November, 200p now....only on AIM

[deanroberthunt] 03/9/2014 08:48

most AIMers are set up to line the pockets of the BOD, not for the benefit of shareholders....this appears to be the former....most are, it's finding the few that are the latter that's the tricky part....like ASOS

[norbus] 03/9/2014 07:21

mcm

you are on the button with the sentiments you record about Dr Akers ; probably why Thomas parted company; TN wanted to grow AKR; Dr wanted the bird in hand I guess

This business likely to go bust if Dr Akers is not restrained.

[mcmather] 02/9/2014 23:03

There were 'one off' costs in Q1 re the listing but admin expenses in Q2 2014 were $1,017,047.

Dr Akers has said all year that the company would be cash neutral this year. However, there was the recent reference alluding to their possibly deciding to invest more in the sales team to generate more sales down the line. I think they call it the jam tomorrow strategy.

The problem here is that after Hendrick and his team came on board - greater expense; refer the $1m admin expenses in the quarter - they increased the area of their focus / sales (PIFA Heparin PF4 / Pluss) year on year by a paltry $37,233.

There has been a lot of bluster spoken about Hendrick / the change in strategy / the company now also selling the PIFA Pluss product in addition to PF4 / sales increasing / etc. What we don't fully know is how much did he and his team cost the company during Q2 2014?

Say the margin was 50% that means 'gross' (increased) revenue of $18,600 or thereabouts.

How much did Hendrick and his team cost the company during Q2 2014??

Should the company be focusing on achieving cash neutral status in 2014 as the good doctor has alluded to for most of the year? Or should they be focusing on providing more funds to Hendrick and others?

It is a tricky one as you do generally need to invest to make a return. But costs need tightening, options need rescinding and if genuine progress is and can be made I would guess very few investors - both here and especially in the US - would object to key personnel being awarded options at a 'fair' price.

Hopefully someone will pose the doctor some decent questions if they can get to the presentation tomorrow evening.

[werewolfie] 02/9/2014 22:15

McM - post 2484. You are saying you are concerned about the high expenditure for Q1 -wasnt that due to one off exceptional costs relating to the NASDAQ float?

[mcmather] 02/9/2014 19:25

It is a move of sorts:

RAUCH GARY M acquired 1020 shares at $3.15 on 22 August 2014.

Humongous purchase - equates to $3213 or £1959 !!



Lets see whether any of the other management team have confidence in the company - ie themselves - by making similar acquisition??

[mcmather] 02/9/2014 12:41

All is generally on track here.

At start of the year they were aiming for $5m revenue. That looks like it will be achieved.

Some reasonable progress has been achieved to date - the contract with 36S signed 7 May 2014 has already secured an order of $864,000.

They have still got $11.5m cash / equivalents.


The progress isn't the problem. The problem is that Dr Akers disposes of a substantial holding, oversees the nasdaq ipo at $5.50, oversees a share price fall down to $3, pays brokers to issue giddy target prices of $11-$13 and then issues options at under $4 and more at $5.50 all within a couple of months!!

Dr Akers frequently quotes that $80m has been invested to date. That the funds raised on nasdaq are to fully commercialise the products and the company.

Surely only a complete bell could fail in such circumstances?? Why then have personnel been awarded options at under $4 and $5.50? What precisely will they have done to have justified the same??

Sadly that appears to send out a loud message to investors but especially nasdaq investors; crikey they can't be happy with those options / the good doctor.

[deanroberthunt] 02/9/2014 12:11

extrapolating the graph we should be at 0p by Xmas....probably 10p more than it's worth :)

[norbus] 02/9/2014 11:10

This goes under NASDAQ where some truly great companies reside.

[deanroberthunt] 01/9/2014 17:46

AIM is just a mechanism for legal fraud.....simples

it's festooned with examples both past and present........

fools gold....

[mcmather] 01/9/2014 13:36

The position still generally stands. The money raised was to oversee the commercialisation of the products. Revenue for the year will be over $5m which is decent progress. New products and contracts are in place.

The problem for me is the expenses - over $1m for the last quarter - and the options at under $4.

You cannot dispose of your own substantial holding.
Then oversee a nasdaq listing at $5.50.
Then oversee a fall down to $3 within a few months.
Then pay brokers to initiate coverage with giddy target prices of $11-$13.
Then talk about new strategies and $80m investment to date with the funds being to commence the real commercialisation phase of the company.
Then talk big.
Then award options at under $4 and others at $5.50.

That is taking people for massive idiots and, in my opinion, this shows the good doctor in an extremely poor and disturbing light.

[deanroberthunt] 01/9/2014 12:27

well, it's done really well since the NASDAQ listing........
back from whence she came......

they'll soon be needing to make something else up to tempt some more suckers....
so the knowing and wise can offload

[deanroberthunt] 01/9/2014 12:26

well, it's done really well since the NASDAQ listing........
back from whence she came......

they'll soon be needing to make something else up to tempt some more suckers....
so the knowing and wise can offload

[mcmather] 01/9/2014 12:05

Yeph, at best it is just extremely stupid. And what message does that send out re the good doctor's business acumen??!